AC Immune’s Parkinson’s Immunotherapy Appears to Slow Disease Progression

By /

In a first for the Parkinson’s field, AC Immune’s immunotherapy has stabilized key biomarkers that suggest an effect on the disease’s course.

Scroll to Top